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Introduction
Clear-cell chondrosarcoma (CCS) was first described by 
Unni in 1976 as a low-grade variant of  chondrosarcoma 
(1). CCS accounts for less than 2% of  the total cases of  
chondrosarcoma; the target population is predominantly 
males between the third and fifth decades of  life (2). CCS 
arises most commonly in the proximal epimetaphyseal re-
gions of  the femur, followed by the humerus, and patients 
present typically with a history of  longstanding local pain 
in the affected limb (2). Radiologically, CCS appears on 
radiographs and CT imaging as a radiolucent lesion in the 
epiphyseal region of  long bones with distinct sclerotic bor-
ders, causing bone expansion, increased calcification, and 
absence of  periosteal reaction and soft-tissue mass (3-5). 
These findings are not specific for CCS and are also shared 
by other bone tumors, including chondroblastoma and 
giant-cell tumor (4). CCS is characterized on MRI by a 
low-to-moderate signal intensity on T1-weighted, and high 
signal intensity on T2-weighted, images (4, 6). The gold 
standard for diagnosis of  CCS remains CT-guided biopsy 
of  the tumor.
Histologically, the tumor displays a lobulated pattern of  
growth. Tumor cells show abundant clear cytoplasm with a 
centrally located nucleus and a prominent nucleolus. Bony 
trabeculae may be prominent; in some cases, a component 
of  conventional chondrosarcoma may be present. Although 
it is a morphologic diagnosis, positive S-100 staining in 
tumor cells can be a useful adjunct (3).
Definitive treatment for CCS is complete surgical resec-
tion of  the tumor with wide margins. Simple excision and 
curettage has been shown in several studies to be associated 
with increased recurrence and worse prognosis and thus is 
not an acceptable treatment option (1, 2). CCS is not sensi-
tive to radiation or chemotherapy; nevertheless, radiation 
therapy is sometimes used to treat lesions that are not ame-
nable to surgical resection (1, 2). The prognosis of  CCS is 
excellent when treated adequately with wide surgical resec-
tion, with the 10 years' disease survival approaching 90%. 
However, CCS has a tendency for very late recurrence and 
metastasis 20 years after initial diagnosis (1, 2, 7). In this 
case report, we present an unusual case of  CCS with early 
multiple bony metastasis.
Case report
A 65-year-old Caucasian male was referred to the ortho-
pedic clinic by his primary care physician for evaluation of  
chronic right proximal humeral pain, increasing in severity 
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over the last 2-3 years. The pain was treated intermittently 
with anti-inflammatory medications before presentation. 
However, these were not adequate, and his arm pain began 
to significantly interfere with daily activities. 
His past medical history included arthritis, hyperlipide-
mia, thyroid disease, and acid reflux. His past surgical his-
tory was notable for thyroid, spinal, and wrist surgeries, all 
for benign conditions. The family history was positive for 
arthritis. He worked in construction, quit smoking 16 years 
ago, and never consumed alcohol. Neurological and muscu-
loskeletal exams were normal during his initial evaluation 
except for decreased range of  motion with flexion, exten-
sion, abduction, and external rotation of  the right shoulder.
A series of  plain-film radiographs performed by his refer-
ring primary care physician to evaluate the right shoulder 
demonstrated dense calcifications within the epiphysis of  
the humeral head that had progressed to involve the meta-
physis, recontouring it. There was also likely involvement of 
the right shoulder joint and glenoid (Fig. 1A). The differen-
tial diagnosis based on the plain radiographs included pri-
mary bone tumors (chondrosarcoma and osteosarcoma), 
secondary lesions such as metastatic disease, lymphoma, 
and Paget’s disease/Pagetoid sarcoma. 
A full diagnostic workup was initiated, including a CT 
and MRI of  the right shoulder. This showed an extensive 
chondroid matrix and extraosseous extension of  the tumor 
compatible with intermediate- to high-grade bone tumor, 
suspicious for chondrosarcoma (Fig. 1B-F). Results of  a CT-
guided needle biopsy of  the tumor were consistent with a 
grade 2 chondrosarcoma, and it ultimately proved to be a 
clear-cell chondrosarcoma of  the humerus with invasion 
into the glenohumeral joint. Further workup with a whole-
body bone scan (Fig. 2) identified a worrisome lesion in the 
right T1 transverse process, and another worrisome lesion 
in the contralateral left femur (measuring 6 x 8 mm), which 
was subsequently biopsied under CT guidance and proved 
to be metastatic clear-cell chondrosarcoma.
The patient underwent extra-articular proximal humerus 
resection (Figs. 3A-B) and segmental proximal humeral 
endoprosthetic reconstruction and radiofrequency ablation 
of  the left femoral lesion and transverse process lesions. 
Histologic examination revealed typical features of  clear-
cell chondrosarcoma (Figs 3C-D).
Following surgery, the patient did well. He did not receive 
any systemic adjuvant therapy on the basis of  the tumor 
subtype and grade. He also remained clinically and radio-
graphically without evidence of  disease for one year follow-
ing surgery. Shortly after his one-year followup, he started 
to experience significant substernal chest pain with short-
ness of  breath, and he was admitted to the hospital. During 
workup for this pain, a CT scan of  the chest demonstrated 
a lesion in the thoracic spine at T2. Further imaging 
workup of  the spine also showed a lesion in the L1 verte-
bral body consistent with metastatic disease, and metastatic 
lesions in the left sacrum and right ilium. Notably, the le-
sion at the T2 level was the most advanced and involved 
the central and right lateral vertebral body, pedicle, and 
posterior elements. There was approximately 50% canal 
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Figure 1. 67-year-old male with clear-cell chondrosarcoma of the 
humerus. A. Plain radiograph of proximal right humerus demon-
strates diffuse sclerosis. Also evident are articular margins, irregu-
larities reconstituted by tumor matrix, ill-defined glenoid, and in-
crease in matrix density in the subcoracoid bursal space. B. Axial 
CT of proximal humerus at tip of coracoids demonstrates intra-
articular bodies and tumor matrix in the medullary canal with disor-
ganized cortical margination and reactive sclerosis. C and D. 
Comparable axial T1 and T2 with fat saturation at inferior glenoid. 
Note complete fat marrow replacement and extension of tumor into 
anteromedial joint recess and expansion of lesser tuberosity. E. 
Coronal inversion recovery demonstrates diffuse marrow involve-
ment, and tumor involving the articular segment and extending into 
the metadiaphyseal junction with permeation of the cortices and 
medial subcoracoid extension into the joint. F. Postgadolinium 
imaging shows heterogeneous enhancing tumor, replacement of 
marrow cavity cortices, and periosteal surface with extension along 
undersurface of the supraspinatus tendon of the rotator cuff and 
diaphyseal satellite lesions.
compromise at this level, but the patient remained neuro-
vascularly intact. He was discharged on a course of  dex-
amethasone treatment with early followup with his ortho-
pedic oncologist. Due to impending neurologic compro-
mise, a low likelihood of  response to systemic or radiation 
treatment, and the absence of  any visceral disease, intrale-
sional decompression and resection of  the metastatic lesion 
at T2, followed by C4 to T5 posterior spinal instrumenta-
tion and fusion, was undertaken. Histologic examination of 
that tumor showed an identical appearance to the patient’s 
primary tumor without high-grade transformation. Three 
years after his initial surgery, the patient has had slowly 
progressive bony disease without other intervention and 
remains asymptomatic; his only disability is poor shoulder 
range of  motion and function due to his shoulder replace-
ment.
Discussion
CCS is a very rare low-grade malignant bone tumor that 
accounts for less than 2% of  all cases of  chondrosarcoma. 
The main diagnostic challenge in CCS is that it typically 
presents with nonspecific symptoms such as longstanding 
limb pain. The radiographic findings are also nonspecific 
and may invoke several benign bone lesions, accounting for 
missed or late diagnosis. In this case, the patient com-
plained of  chronic pain in his right shoulder for several 
years. Although his primary care physician followed him 
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Figure 3. 67-year-old male with clear-cell chondrosarcoma 
of the humerus. A. Resection specimen shows epi-
metaphyseal-based lesion with cortical invasion. B. Resec-
tion specimen shows intra-articular tumor loose bodies (ar-
rows). C. Sheets of clear cells with scattered multinucleated 
giant cells and bony trabeculae (H&E x200). D. Transition to 
hyaline cartilage-rich foci (H&E x200).
Figure 2. 67-year-old male with clear-cell chondrosarcoma 
of the humerus. Technetium MDP total body bone scan with 
notable uptake in primary tumor location in right shoulder, 
secondary site uptake in mid left femur, and right transverse 
process of T1 consistent with metastatic disease.
with serial radiographs, the radiographic findings were very 
subtle and nonspecific, leading to a late diagnosis of  his 
tumor. 
As reported in the literature, the majority of  CCS cases 
are characterized by a protracted clinical course with a low 
rate of  recurrence and metastasis, which may occur many 
years after initial diagnosis. However, it is important to rec-
ognize that (rarely) CCS may recur and/or metastasize 
early, despite complete surgical resection. Currently, no 
diagnostic features or markers predict which tumors are 
associated with early recurrence and worse prognosis. In-
terestingly, CCS tumors presenting in the proximal hu-
merus have been associated with more aggressive radiologi-
cal features, and a more aggressive clinical course com-
pared to lesions in other long bones (4, 7). Notably, a report 
by Corradi et al. (8) compared the morphologic features of  
low-grade to aggressive cases of  CCS. The authors con-
cluded that aggressive CCS are characterized histopathogi-
cally by the presence of  tumor cells with decreased cell dif-
ferentiation, evidenced by round cell membranes lacking 
microvilli (which are typical of  the low-grade tumors) and 
by more widespread staining for matrix metalloproteinase 2 
(MMP-2), known to be important for tumor invasion and 
metastasis (9). Other groups have tried to identify novel 
diagnostic features that may help in the diagnosis and fol-
lowup of  CCS. A report by Ogose et al. in 2001 showed 
that CCS secreted serum alkaline phosphatase (SAP), sug-
gesting that SAP may be used as a tumor marker for CCS 
(10). Donati et al. recently tested this hypothesis by compar-
ing the levels of  SAP pre- and post-surgical resection of  
CCS (7). In 11 out of  the 17 patients, SAP levels were ele-
vated. The majority of  cases with elevated SAP levels be-
fore surgery had decreased or returned to normal following 
resection. Importantly, 4 cases with later CCS recurrence 
were also evaluated for SAP blood levels, and in 3 out of  
the 4 cases, SAP levels were increased, suggesting that SAP 
may be an important diagnostic adjunct to be used in addi-
tion to radiological imaging for diagnosis, treatment, and 
followup of  patients with CCS (7). 
In conclusion, while the vast majority of  cases of  CCS 
pose only a local problem with low metastatic potential, 
rare cases of  CCS behave in an aggressive fashion and re-
quire close monitoring. Tumor characteristics found to cor-
relate with aggressive behavior include tumor location 
(proximal humerus), poor tumor differentiation on histopa-
thology with widespread positive MMP-2 staining, and 
increased SAP levels following resection of  tumor. The 
presence of  any of  these features may be used clinically to 
identify the subset of  CCS with the potential for aggressive 
behavior. 
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